Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen Licenses MDx Technology to Swedish Firm

NEW YORK (GenomeWeb News) – Nanogen said today that it has licensed to Scandinavian Gene Synthesis the rights to its MGB Probe technology and synthetic nucleic acid chemistries and dyes and quenchers.

Under the licensing deal, SGS has the right to use its own cGMP manufacturing capabilities to make and sell molecular diagnostic products incorporating Nanogen's technology. In return, Nanogen will receive an upfront license fee and a commitment for Nanogen to supply component products for use by SGS in designing and manufacturing custom DNA oligonucleotides for the molecular diagnostics market.

Further terms of the pact were not disclosed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more